全球肉毒毒素市场发展趋势

自1989年肉毒毒素首次被FDA批准治疗斜视之后,在全球肉毒毒素共被超过88个国家批准了29个适应症。近20年来其稳定的治疗效果和安全性已经逐步得到了广泛的认可,从最初的用来治疗眼睑痉挛、面肌痉挛、痉挛性斜颈、斜视等到后来的逐步批准应用于美容领域。目前全球肉毒毒素品牌共有10多个,本文就全球肉毒毒素市场发展趋势作简要分析阐述。

Since FDA’s first approved of Botox in the treatment of strabismus in 1989, botulinum toxin is registered in more than 88 countries worldwide, with a number of 29 indications. For the past 20 years , its stable therapeutic effect and safety has gradually been widely recognized, from treating blepharospasm , hemifacial spasm , spasmodic torticollis , strabismustothe medical aestheticarea. There are more than 10 brands of botulinum toxin currently, this paper tends to analyztheglobal botulinum toxin market trends and its impact on China.